孩子王(301078.SZ):首款自研AI玩具“啊貝貝”已經上市
格隆匯7月29日丨孩子王(301078.SZ)在投資者互動平臺表示,公司首款自研AI玩具“啊貝貝”已經上市,在孩子王APP及小程序、線下門店均有銷售,目前銷售情況良好,具體的銷售數據可關注公司發佈的定期報告。後續,公司將持續升級AI玩具產品,探索推進渠道專款或聯名款,並會加大三方AI產品拓展,以充分發揮公司的全渠道、全場景、數智化優勢。鑑於公司AI產品尚處於初步發展階段,在公司業務中佔比較小,對公司業績不構成重大影響,敬請投資者謹慎決策,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.